{"id":"https://openalex.org/W7129587331","doi":"https://doi.org/10.1111/jdv.70362","title":"Efficacy of abrocitinib and dupilumab in itch\u2010dominant atopic dermatitis: An analysis of 2 trials","display_name":"Efficacy of abrocitinib and dupilumab in itch\u2010dominant atopic dermatitis: An analysis of 2 trials","publication_year":2026,"publication_date":"2026-02-17","ids":{"openalex":"https://openalex.org/W7129587331","doi":"https://doi.org/10.1111/jdv.70362","pmid":"https://pubmed.ncbi.nlm.nih.gov/41700643"},"language":"en","primary_location":{"id":"doi:10.1111/jdv.70362","doi":"https://doi.org/10.1111/jdv.70362","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.70362","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70362","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70362","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011739266","display_name":"Jonathan I. Silverberg","orcid":"https://orcid.org/0000-0003-3686-7805","observed_orcids":["https://orcid.org/0000-0003-3686-7805"]},"institutions":[{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan I. Silverberg","raw_affiliation_strings":["The George Washington School of Medicine and Health Sciences  Washington DC USA"],"raw_orcid":"https://orcid.org/0000-0003-3686-7805","affiliations":[{"raw_affiliation_string":"The George Washington School of Medicine and Health Sciences  Washington DC USA","institution_ids":["https://openalex.org/I193531525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013549423","display_name":"Marjolein S. de Bruin-Weller","orcid":"https://orcid.org/0000-0002-1249-6993","observed_orcids":["https://orcid.org/0000-0002-1249-6993"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marjolein de Bruin\u2010Weller","raw_affiliation_strings":["National Expertise Center for Atopic Dermatitis University Medical Center  Utrecht Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Expertise Center for Atopic Dermatitis University Medical Center  Utrecht Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069703619","display_name":"Javier Ortiz-De Frutos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Ortiz de Frutos","raw_affiliation_strings":["Hospital Universitario 12 de Octubre  Madrid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario 12 de Octubre  Madrid Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104165179","display_name":"Juan Francisco Silvestre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137674","display_name":"Hospital General Universitario de Alicante Doctor Balmis","ror":"https://ror.org/02ybsz607","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210137674"]},{"id":"https://openalex.org/I4387154003","display_name":"Instituto de Investigaci\u00f3n Sanitaria y Biom\u00e9dica de Alicante (ISABIAL)","ror":"https://ror.org/00zmnkx60","country_code":"ES","type":"facility","lineage":["https://openalex.org/I111262870","https://openalex.org/I130194489","https://openalex.org/I2802828525","https://openalex.org/I4210095330","https://openalex.org/I4210137674","https://openalex.org/I4387154003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan Francisco Silvestre","raw_affiliation_strings":["Hospital General Universitario Dr Balmis\u2010ISABIAL  Alicante Spain"],"raw_orcid":"https://orcid.org/0000-0002-8532-6338","affiliations":[{"raw_affiliation_string":"Hospital General Universitario Dr Balmis\u2010ISABIAL  Alicante Spain","institution_ids":["https://openalex.org/I4210137674","https://openalex.org/I4387154003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119232608","display_name":"Brian Esparza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Esparza","raw_affiliation_strings":["Pfizer Inc.  Collegeville Pennsylvania USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc.  Collegeville Pennsylvania USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089457810","display_name":"Daniela E. Myers","orcid":"https://orcid.org/0000-0003-1426-9919","observed_orcids":["https://orcid.org/0000-0003-1426-9919"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniela E. Myers","raw_affiliation_strings":["Pfizer Inc.  New York New York USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc.  New York New York USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079043748","display_name":"Pinaki Biswas","orcid":"https://orcid.org/0009-0009-3494-4142","observed_orcids":["https://orcid.org/0009-0009-3494-4142"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pinaki Biswas","raw_affiliation_strings":["Pfizer Inc.  New York New York USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc.  New York New York USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043855959","display_name":"Irene Hern\u00e1ndez\u2010Mart\u00edn","orcid":"https://orcid.org/0000-0001-9620-0485","observed_orcids":["https://orcid.org/0000-0001-9620-0485"]},"institutions":[{"id":"https://openalex.org/I4210138890","display_name":"Pfizer (Spain)","ror":"https://ror.org/03x2xt559","country_code":"ES","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210138890"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Irene Hern\u00e1ndez\u2010Mart\u00edn","raw_affiliation_strings":["Pfizer S.L.U  Madrid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer S.L.U  Madrid Spain","institution_ids":["https://openalex.org/I4210138890"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065130489","display_name":"Erman G\u00fcler","orcid":"https://orcid.org/0009-0006-1240-5269","observed_orcids":["https://orcid.org/0009-0006-1240-5269"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Erman G\u00fcler","raw_affiliation_strings":["Pfizer Inc.  Istanbul Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc.  Istanbul Turkey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126189584","display_name":"Marina Mikheil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marina Mikheil","raw_affiliation_strings":["Pfizer Inc.  Collegeville Pennsylvania USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc.  Collegeville Pennsylvania USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025634637","display_name":"Raj Chovatiya","orcid":"https://orcid.org/0000-0001-6510-399X","observed_orcids":["https://orcid.org/0000-0001-6510-399X"]},"institutions":[{"id":"https://openalex.org/I189273616","display_name":"Rosalind Franklin University of Medicine and Science","ror":"https://ror.org/04fegvg32","country_code":"US","type":"education","lineage":["https://openalex.org/I189273616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raj Chovatiya","raw_affiliation_strings":["Center for Medical Dermatology + Immunology Research  Chicago Illinois USA","Chicago Medical School Rosalind Franklin University of Medicine and Science  North Chicago Illinois USA"],"raw_orcid":"https://orcid.org/0000-0001-6510-399X","affiliations":[{"raw_affiliation_string":"Center for Medical Dermatology + Immunology Research  Chicago Illinois USA","institution_ids":[]},{"raw_affiliation_string":"Chicago Medical School Rosalind Franklin University of Medicine and Science  North Chicago Illinois USA","institution_ids":["https://openalex.org/I189273616"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5065130489"],"corresponding_institution_ids":[],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":{"value":5450,"currency":"USD","value_usd":5450},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09258524,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"7","first_page":"e614","last_page":"e617"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abrocitinib","display_name":"abrocitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dupilumab","display_name":"dupilumab","score":1.0},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.9100000262260437},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.8529999852180481},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.7260000109672546},{"id":"https://openalex.org/keywords/anti-ige-therapy","display_name":"anti-IgE therapy","score":0.734000027179718},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9811000227928162},{"id":"https://openalex.org/C2780699399","wikidata":"https://www.wikidata.org/wiki/Q20708049","display_name":"Eczema Area and Severity Index","level":3,"score":0.9014000296592712},{"id":"https://openalex.org/C2779824493","wikidata":"https://www.wikidata.org/wiki/Q5315925","display_name":"Dupilumab","level":3,"score":0.8422999978065491},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.7986000180244446},{"id":"https://openalex.org/C2776173921","wikidata":"https://www.wikidata.org/wiki/Q25326609","display_name":"Dermatology Life Quality Index","level":3,"score":0.770799994468689},{"id":"https://openalex.org/C2779923671","wikidata":"https://www.wikidata.org/wiki/Q199602","display_name":"Itching","level":2,"score":0.7170000076293945},{"id":"https://openalex.org/C2776233030","wikidata":"https://www.wikidata.org/wiki/Q17149812","display_name":"Janus kinase inhibitor","level":4,"score":0.6654000282287598},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.6179999709129333},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5723999738693237},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5245000123977661},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4966999888420105},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.46619999408721924},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.4595000147819519},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.43849998712539673},{"id":"https://openalex.org/C2780501606","wikidata":"https://www.wikidata.org/wiki/Q7389221","display_name":"SCORAD","level":4,"score":0.4154999852180481},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3601999878883362},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3400999903678894},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.31040000915527344},{"id":"https://openalex.org/C2781464078","wikidata":"https://www.wikidata.org/wiki/Q7685898","display_name":"Target lesion","level":4,"score":0.30970001220703125},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.3073999881744385},{"id":"https://openalex.org/C2992053201","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Clinical efficacy","level":2,"score":0.2989000082015991},{"id":"https://openalex.org/C2780938799","wikidata":"https://www.wikidata.org/wiki/Q2853347","display_name":"Antipruritic","level":2,"score":0.28929999470710754},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.28450000286102295},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.2678999900817871}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1111/jdv.70362","doi":"https://doi.org/10.1111/jdv.70362","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.70362","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70362","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},{"id":"pmid:41700643","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41700643","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology : JEADV","raw_type":"Letter"},{"id":"pmh:oai:dspace.library.uu.nl:1874/487307","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/487307","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:13308663","doi":null,"is_oa":true,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41700643/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"J Eur Acad Dermatol Venereol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/jdv.70362","doi":"https://doi.org/10.1111/jdv.70362","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.70362","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70362","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Responsible consumption and production","score":0.4343954622745514,"id":"https://metadata.un.org/sdg/12"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7129587331.pdf","grobid_xml":"https://content.openalex.org/works/W7129587331.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W3136297743","https://openalex.org/W3141990528","https://openalex.org/W4224326447","https://openalex.org/W4381189146"],"related_works":[],"abstract_inverted_index":{"Efficacy":[0],"of":[1],"abrocitinib":[2],"and":[3]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2026-02-18T00:00:00"}